No Data
Is Regulus Therapeutics Inc. (RGLS) the Best Rising Penny Stock to Buy According to Analysts?
New Analyst Forecast: $RGLS Given 'Overweight' Rating
Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
Regulus Therapeutics Leads The Charge Among 3 Promising Penny Stocks
Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7
Wells Fargo Upgrades Regulus Therapeutics(RGLS.US) to Buy Rating, Raises Target Price to $6